Reuters -- Sanofi, Carlyle in Talks to Buy Elder Pharma's India Formulations Business: Sources

Sanofi SA's India unit and Carlyle Group are in separate talks to buy the domestic drug formulations business of India's Elder Pharmaceuticals Ltd for $400 million-$450 million, sources told Reuters.

DealsNorth AmericaUSBriefs